RxDoctor Payments Data

Ian Mackey

Physician Assistant · Skokie, ILNPI 1720109424

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $88,961 of the $134,991 with a category attached, or 65.9%. 39 manufacturers reported payments, led by Johnson & Johnson at 44.3% of the total. 2025 is the largest year on record at $60,582, 5.9 times the $10,335 reported in 2021. Among physician assistant clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$134,991in general payments, 2019–2025

Across 1,181 payments — averaging $114.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$60K
  • Axsome Therapeutics, Inc.$52K
  • Janssen Scientific Affairs, LLC$4K
  • AbbVie$3K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
  • Teva Pharmaceuticals USA, Inc.$2K
  • plus $12K from 33 others

What the payments were for

  • Consulting fees$12,0549%
  • Speaking & faculty fees$88,96166%
  • Travel & lodging$10,4878%
  • Food & beverage$23,19817%
  • Education$2920%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$134,991 in reported general payments places this provider in the 95th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide23$22,628
Lurasidone Hcl11$18,730
OzempicSemaglutide12$9,338
Tranylcypromine Sulfate11$5,204
Quetiapine Fumarate ErQuetiapine Fumarate12$1,784
Divalproex Sodium ErDivalproex Sodium14$1,465
Bupropion XlBupropion Hcl59$1,213
Aripiprazole26$1,197
Vilazodone Hcl14$944
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine19$910
Clonazepam89$838
Phenelzine Sulfate12$713
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine38$609
Haloperidol15$547
Lorazepam58$491

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$967$22,62823 claims
Novo NordiskOzempic$87$9,33812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Skokie

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →